WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H413656
CAS#: 12539-23-0
Description: Vangatalcite is a biochemical
Hodoodo Cat#: H413656
Name: Vangatalcite
CAS#: 12539-23-0
Chemical Formula: CH18Al2Mg4O18
Exact Mass: 467.95
Molecular Weight: 469.320
Elemental Analysis: C, 2.56; H, 3.87; Al, 11.50; Mg, 20.72; O, 61.36
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Vangatalcite; MA20; MA 20; MA-20
IUPAC/Chemical Name: dialuminum(III) tetramagnesium carbonate dodecahydroxide trihydrate
InChi Key: HITXWGXAPHJXHJ-UHFFFAOYSA-A
InChi Code: InChI=1S/CH2O3.2Al.4Mg.15H2O/c2-1(3)4;;;;;;;;;;;;;;;;;;;;;/h(H2,2,3,4);;;;;;;15*1H2/q;2*+3;4*+2;;;;;;;;;;;;;;;/p-14
SMILES Code: [O-]C([O-])=O.O.O.O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3]
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 469.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Borm KJ, Oechsner M, Düsberg M, Buschner G, Weber W, Combs SE, Duma MN. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design. Radiother Oncol. 2020 Jan;142:195-201. doi: 10.1016/j.radonc.2019.08.021. Epub 2019 Sep 17. PMID: 31540747.
2: Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN; MA.20 Study Investigators. Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340. PMID: 26200977; PMCID: PMC4556358.
3: Gross JP, Whelan TJ, Parulekar WR, Chen BE, Rademaker AW, Helenowski IB, Donnelly ED, Strauss JB. Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):165-173. doi: 10.1016/j.ijrobp.2019.05.002. Epub 2019 May 11. PMID: 31085285.
4: Bornheim S, Croisier JL, Maquet P, Kaux JF. Transcranial direct current stimulation associated with physical-therapy in acute stroke patients - A randomized, triple blind, sham-controlled study. Brain Stimul. 2020 Mar- Apr;13(2):329-336. doi: 10.1016/j.brs.2019.10.019. Epub 2019 Oct 31. PMID: 31735645.
5: de Jel DVC, Hol JA, Ooms AHAG, de Krijger RR, Jongmans MCJ, Littooij AS, Drost J, van Grotel M, van den Heuvel-Eibrink MM. Paediatric metanephric tumours: a clinicopathological and molecular characterisation. Crit Rev Oncol Hematol. 2020 Jun;150:102970. doi: 10.1016/j.critrevonc.2020.102970. Epub 2020 Apr 24. PMID: 32371339.
6: Bershad AK, Mayo LM, Van Hedger K, McGlone F, Walker SC, de Wit H. Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacology. 2019 Sep;44(10):1698-1705. doi: 10.1038/s41386-019-0402-z. Epub 2019 Apr 30. PMID: 31042696; PMCID: PMC6785008.
7: Bashir S, Al-Hussain F, Hamza A, Asim Niaz T, Albaradie R, Habib SS. Cognitive function assessment during 2 mA transcranial direct current stimulation in DLPFC in healthy volunteers. Physiol Rep. 2019 Oct;7(20):e14264. doi: 10.14814/phy2.14264. PMID: 31660693; PMCID: PMC6817993.
8: Lui GK, McGarry C, Bhatt A, Book W, Riehle-Colarusso TJ, Dunn JE, Glidewell J, Gurvitz M, Hoffman T, Hogue CJ, Hsu D, Obenhaus S, Raskind-Hood C, Rodriguez FH 3rd, Zaidi A, Van Zutphen AR. Surveillance of Congenital Heart Defects among Adolescents at Three U.S. Sites. Am J Cardiol. 2019 Jul 1;124(1):137-143. doi: 10.1016/j.amjcard.2019.03.044. Epub 2019 Apr 10. PMID: 31030970.
9: Dobbs B, Pawlak N, Biagioni M, Agarwal S, Shaw M, Pilloni G, Bikson M, Datta A, Charvet L. Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson's disease. J Neuroeng Rehabil. 2018 Dec 7;15(1):114. doi: 10.1186/s12984-018-0457-9. PMID: 30522497; PMCID: PMC6284269.
10: Ortiz C, Rondeau NU, Moore LE, Mulla ZD. Parental Age and the Risk of Gestational Hypertension and Preeclampsia. South Med J. 2018 Sep;111(9):544-548. doi: 10.14423/SMJ.0000000000000854. PMID: 30180252.
